Synthesis of a first estradiol-adenosine hybrid compound

Synthetic Communications

Volumn 33, Issue 18, 2003, Pages 3183-3192

  Poirier, Donald ^a   Boivin, Roch P ^a   Bérubé, Marie ^a   Lin, Sheng Xiang ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

17 hydroxysteroid dehydrogenase; Adenosine; Enzyme; Estradiol; Inhibitor; Steroid

Indexed keywords

5' O [3 [3',17'BETA DIHYDROXYL 1',3' 5'(10') ESTRATRIEN 16'ALPHA YL]PROPANOYL]ADENOSINE; ADENOSINE DERIVATIVE; CARBON; ENZYME INHIBITOR; ESTER; ESTRADIOL DERIVATIVE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; COMPLEX FORMATION; DRUG DESIGN; DRUG SYNTHESIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HORMONE STRUCTURE; HYBRID; MOLECULAR INTERACTION; PROTEIN DOMAIN; REACTION ANALYSIS; TECHNIQUE;

EID: 0042835739     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-120023440     Document Type: Article

References (18)

1. Horwitz, K.B.; McGuire, W.L. Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem. 1978, 253, 8185.
2. Dickson, R.B.; Lippman, M.E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev. 1987, 8, 29.
3. Poulin, R.; Labrie, F. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res. 1986, 46, 4933.
4. Gurpide, E.; Gusberg, S.B.; Tseng, L. J. Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma. Steroid Biochem. 1976, 7, 891.
5. Labrie, F. Intracrinology. Molec. Cell. Endocr. 1991, 78, C113.
6. Luu-The, V.; Zhang, Y.; Poirier, D.; Labrie, F. J. Characteristics of human types 1, 2 and 3 17beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. Steroid Biochem. Molec. Biol. 1995, 55, 581.
7. Labrie, F.; Luu-The, V.; Lin, S.X.; Labrie, C.; Simard, J.; Breton, R.; Bélanger, A. The key role of 17beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62, 148.
8. Penning, T.M. 17beta-hydroxysteroid dehydrogenase: inhibitors and inhibitor design. Endocrine-Related Cancer 1996, 3, 41.
9. Tremblay, M.R.; Lin, S.X.; Poirier, D. Chemical synthesis of 16beta-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17beta-hydroxysteroid dehydrogenase and binding affinity on steroid receptors. Steroids 2001, 66, 821.
10. Tremblay, M.R.; Poirier, D. J. Overview of a rational approach to design type 1 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation. Steroid Biochem. Molec. Biol. 1998, 66, 179.
11. Poirier, D.; Dionne, P.; Auger, S. J. A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1. Steroid Biochem. Molec. Biol. 1998, 64, 83.
12. Pelletier, J.D.; Labrie, F.; Poirier, D. N-butyl, N-methyl, 11-[3′,17′ beta-(dihydroxy)-1′,3′,5′(10′ )-estratrien-16′ alpha-yl]-9(R/S)-bromo undecanamide: synthesis and 17 beta-HSD inhibiting, estrogenic and antiestrogenic activities. Steroids 1994, 59, 536.
13. Ha, S.B.; Nair, V. An improved approach to the synthesis of adenosine-5′-N-ethyluronamides of interest as adenosine receptor agonists. Tetrahedron Lett. 1996, 37, 1567.
14. Hampton, A. J. Nucleotides. II. A new procedure for the conversion of ribonucleosides to 2′,3′-O-isopropylidene derivatives. Am. Chem. Soc. 1961, 83, 3640.
15. Mitsunobu, O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1981, 1.
16. Shimokawa, S.; Kimura, J.; Mitsunobu, O. Studies on nucleosides and nucleotides. V. Selective aroylation of 5′-hydroxyl group of uridine and adenosine. Bull. Chem. Soc. Jpn. 1976, 49, 3357.
17. Gish, D.T.; Kelly, R.C.; Camiener, G.W.; Wechter, W.J. Nucleic acids. II. Synthesis of 5′-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity. J. Med. Chem. 1971, 14, 1159.
18. Miyashita, T.; Ashida, N.; Kondoh, K.; Sakata, S.; Machida, H.; Fujii, A.; Ueda, T.; Matsuda, A. Synthesis and antitumor activity of acyl and benzyl types of prodrugs of 2′-deoxy-2′-methylidenecytidine. Nucleosides & Nucleotides 1992, 11, 495.